Dominant-negative Protein Inhibition
Dominant-negative Protein Inhibition - Related Videos
08:35
Inducible and Reversible Dominant-negative (DN) Protein Inhibition
0 Views •
2019
Here we present a protocol to develop a dominant-negative inducible system, in which any protein can be conditionally inactivated by reversibly overexpressing a dominant-negative mutant version of it.
01:29
Dominant and Dominated Strategies
0 Views •
2025
In strategic decision-making, a dominant strategy is one that always provides the best outcome for a player, no matter what the other players decide. This ensures that the player's payoff is maximized regardless of the choices made by others. On the other hand, a dominated strategy consistently leads to a worse outcome than another available strategy, regardless of the opponent's decision. For instance, imagine two firms competing in a market by setting production levels—either high or low.
01:43
Incomplete Dominance
0 Views •
2021
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism. According to Mendel, organisms with both copies or a single copy of the dominant allele display a...
03:34
Assessing Social Dominance in Mouse Models Using the Tube Test
0 Views •
Cited by 1 •
2025
This protocol describes a behavioral assay to evaluate social dominance in rodents using the tube test. Social dominance remains stable over time, and several models of developmental and neurological disorders exhibit robust social dominance abnormalities. Therefore, the tube test serves as a convenient outcome measure for mechanistic studies or preclinical therapeutic screening.
01:23
Negative Regulator Molecules
0 Views •
2019
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria. Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e., cancer). These...
FAQs
Dominant-negative effects can arise when mutant and wild-type proteins normally assemble into multimers, or complexes made of multiple protein subunits. Incorporation of a defective subunit can prevent the entire complex from functioning, even when normal protein remains available. Consequently, the complex’s subunit composition and assembly requirements become central to interpreting how a specific variant alters cellular activity.
A mutant protein may compete with the normal protein for DNA, another target, or an essential binding site. It may also sequester partners or cellular components, making them unavailable for normal activity. These mechanisms differ in their immediate molecular targets, so identifying the interaction being disrupted helps explain the resulting phenotype and distinguish among possible variant effects.
A functional allele may produce normal protein, but that protein can become ineffective when the mutant product interferes with assembly, target binding, or access to essential partners. The relevant genetic question is therefore not only how much normal protein is made, but whether the mutant alters the behavior of the shared protein system. This helps explain phenotypes despite one remaining functional allele.
A mechanism-focused analysis can compare the mutant and wild-type proteins, then examine whether the variant affects multimer formation, competes for DNA or other targets, or sequesters partners and cellular components. Researchers can relate those molecular observations to cellular function. This approach distinguishes a specific dominant-negative mechanism from an undifferentiated loss of gene-product activity.
Studying dominant-negative variants can support disease modeling by linking a particular mutation to disruption of a protein system rather than considering only the loss of one gene product. It also supports functional analysis of gene products, especially when proteins act in complexes. These investigations help connect molecular interactions with inheritance patterns and observed phenotypes.
The mechanism can guide strategies that selectively reduce mutant protein activity or restore normal cellular function. The relevant target depends on how the variant acts: interference may involve binding the normal protein, competing for DNA or another target, or sequestering an essential partner. Matching intervention goals to the specific interaction provides a rational framework for addressing mutant effects.